AbbVie aims for new drugs to boost sales as competitors target humira

Company says two newer immune drugs can offset the blockbuster's decline, and it plans to lift a cap on the size of deals it will do.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...